Scarica l'app Stockscreener
0.3601
2.39%
0.0084
Precedente Chiudi:
$0.3517
Aprire:
$0.35
Volume 24 ore:
1.63M
Relative Volume:
0.12
Capitalizzazione di mercato:
$57.30M
Reddito:
$506.20K
Utile/perdita netta:
$-41.69M
Rapporto P/E:
-1.3661
EPS:
-0.2636
Flusso di cassa netto:
$-33.02M
1 W Prestazione:
-6.93%
1M Prestazione:
-16.64%
6M Prestazione:
-79.30%
1 anno Prestazione:
-86.04%
Intervallo 1D:
$0.32
$0.3667
Intervallo di 1 settimana:
$0.32
$0.4164
Portata 52W:
$0.20
$3.05
Mereo Biopharma Group Plc Adr Stock (MREO) Company Profile
Nome
Mereo Biopharma Group Plc Adr
Settore
Industria
Telefono
4403330237300
Indirizzo
ONE CAVENDISH PLACE, LONDON
Compare MREO vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MREO
Mereo Biopharma Group Plc Adr
|
0.3601 | 55.97M | 506.20K | -41.69M | -33.02M | -0.2636 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.39 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
739.12 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
683.81 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.34 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.10 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mereo Biopharma Group Plc Adr Stock (MREO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-30 | Downgrade | Jefferies | Buy → Hold |
| 2025-03-27 | Iniziato | JP Morgan | Overweight |
| 2024-12-06 | Iniziato | Jefferies | Buy |
| 2024-06-13 | Iniziato | Robert W. Baird | Outperform |
| 2023-10-13 | Ripresa | BTIG Research | Buy |
| 2022-08-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-05-05 | Iniziato | BTIG Research | Buy |
| 2021-04-05 | Iniziato | Needham | Buy |
Mostra tutto
Mereo Biopharma Group Plc Adr Borsa (MREO) Ultime notizie
Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights - Investing News Network
Mereo BioPharma (NASDAQ: MREO) details 2025 loss and cash runway to 2027 - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO - FinancialContent
Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
MREO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 - ChartMill
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com
MREO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 - Barchart.com
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit - Sahm
Class Action Filed Against Mereo BioPharma Group plc (MREO)April 6, 2026 Deadline to JoinContact The Gross Law Firm - Barchart.com
Pomerantz LLP Issues Reminder to Investors in Mereo BioPharma Group plc of Class Action Filing – MREO - ACCESS Newswire
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026 - Barchart.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming DeadlinesMREO - Sahm
UPCOMING DEADLINE: Mereo BioPharma (MREO) Securities Fraud Class Action – April 6, 2026 Lead Plaintiff DeadlineFaruqi & Faruqi LLP - ChartMill
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo LawsuitMREO - Barchart.com
Mereo BioPharma Group plcSponsored ADR (NASDAQ:MREO) Given Consensus Rating of "Hold" by Analysts - MarketBeat
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 - Barchart.com
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo BioPharma Group plc LawsuitMREO - Barchart.com
Shareholders who lost money in shares of Mereo BioPharma Group PLC (NASDAQ: MREO) should contact Wolf Haldenstein immediately - ChartMill
NASDAQ: MREO INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors of an April 6, 2026 Deadline - ChartMill
Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO - marketscreener.com
Nasdaq bid-price warning puts Mereo BioPharma (NASDAQ: MREO) listing at risk - Stock Titan
Mereo BioPharma Faces Securities Litigation - Intellectia AI
MREO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 - ChartMill
Mereo BioPharma Group plc Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before April 6, 2026 to Discuss Your RightsMREO - ChartMill
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 - Barchart.com
Mereo BioPharma Faces Class Action Lawsuit - Intellectia AI
MREO Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Mereo BioPharma Group plc - Sahm
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Mereo BioPharma - Chartmill
Mereo Biopharma Group Plc Adr Azioni (MREO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
1.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):